The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials. These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
Timeframe: 3 months
Number of tardive dyskinesia study participants who remain in clinical study until completion.
Timeframe: 12 months